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Abstract
A report of the 23rd Protein Symposium ‘Proteins in Motion’, 
Boston, USA, 23-27 July 2009.
This year, the annual symposium of the Protein Society 
highlighted the dynamic motions that enable almost all 
protein function. The ability of polypeptide protein chains 
to adopt intricate and highly-defined shapes, as elucidated 
in crystal structures, has long been appreciated for 
enabling the multitude of functions that proteins carry out. 
More recently, as the field of protein science has pro-
gressed, it has become clear that all proteins are in 
constant motion and that protein motions have a 
tremendous influence on function. The meeting covered a 
broad array of protein functions, experimental approaches, 
and scales from single molecules to signaling networks and 
complex cellular organizations. In this report, we describe 
a small fraction of these presentations that are repre sen-
tative of both influential contributions and new directions 
of the field.
Dynamic proteins and complexes
Beyond the beautiful static structures that we see using 
crystallography, proteins are inherently dynamic, and 
many sample a plethora of different conformations. While 
dynamics are vital to the function of virtually all proteins, a 
major goal is to understand the dynamics of two types of 
proteins that have critical roles in many human diseases: 
intrinsically disordered proteins, and proteins that aggre-
gate to form amyloid-like fibrils. These proteins are not 
easily studied by classic crystallographic techniques, but 
instead highlight the importance of nuclear magnetic 
resonance (NMR) and other biophysical methods to study 
conformational changes and dynamics. Intrinsically dis-
ordered proteins often have short amphipathic regions with 
no regular structure until complexed with specific binding 
partners. As a family, these proteins are predicted to comprise 
a significant proportion of the eukaryotic proteome, where 
many of them function as ‘hubs’ in protein-interaction 
networks, interacting with numerous partner proteins.
Peter Wright (Scripps Research Institute, La Jolla, USA) 
focused on NMR studies of intrinsically disordered 
proteins, such as the transcriptional coactivators CREB-
binding protein (CBP) and p300, and the tumor suppressor 
p53, to gain structural insights into their transformation 
from disordered to structured on binding their partners. 
The free-energy cost associated with folding of the 
disordered regions results in weaker interactions with high 
specificity that can readily dissociate to terminate a 
signaling event. Taking disordered proteins to the next 
level, Julie Forman-Kay (Hospital for Sick Children, 
Toronto, Canada) described how the functions of highly 
dynamic protein complexes can be modulated by post-
translational modifications. NMR experiments with the 
cystic fibrosis transmembrane regulator (CFTR) indicate 
that the regulatory region of this protein is prone to 
intrinsic disorder; the balance between assuming structure 
and binding to the nucleotide-binding region and disorder 
is modulated by phosphorylation of the regulatory region. 
Raymond Norton (Walter and Eliza Hall Institute of 
Medical Research, Melbourne, Australia) presented struc-
tural studies on an intrinsically disordered protein, MSP2, 
that is a major surface protein on Plasmodium falciparum 
and an important candidate for an anti-malarial vaccine. In 
solution, MSP2 is largely unstructured, but appears to form 
fibrils, which are predicted to be biologically relevant when 
present on the surface of the parasite.
Many different proteins (some of which are also intrin-
sically disordered) have been shown to aggregate into 
amyloid-like fibrils, which are the hallmarks of several 
neurodegenerative diseases. Jean Baum (Rutgers Uni-
versity, Piscataway, USA) presented the results of NMR 
experiments along with molecular simulations that indicate 
the rate of aggregation of α-synuclein (in Parkinson’s 
disease) is dependent on the pH and aspects of protein 
sequence, including charge distribution. Using comple-
mentary approaches, Yuji Goto (Osaka University, Japan) 
described how ultrasonication can create mono dispersed 
minimal fibrils of β2-microglobulin (implicated in Alzheimer’s 
disease) that can be readily studied in vitro. Fluorescence 
microscopy and hydrogen/deuterium exchange NMR 
experiments were then used to follow the kinetics and 
mechanism of subsequent fibril nucleation and growth at 
high resolution. A major goal of these studies is a detailed 
understanding of how normal proteins can aggregate into 
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higher-order structures, and how to prevent such aggre-
gation, with the hope of developing successful therapeutic 
approaches to treat amyloid-based human diseases.
Multivalent association and higher-order 
organization
The combination of multiple contact points between 
associated molecules leads to tighter binding than for 
individual contact points in isolation. This intuitively 
simple concept is vital to the function of many important 
protein systems and was widely discussed at the meeting. 
A number of speakers presented data indicating that multi-
valent interfaces in repeat-containing proteins or homo-
oligomers lead to stabilization of protein structure. This 
reservoir of stability is thought to serve as a capacitor for 
functional evolution of these proteins by maintaining 
structure in the face of destabilizing mutations that 
increase the potential for altered or novel function.
Experimental approaches demonstrated the influential 
role of multivalent association on protein stability. Doug 
Barrick (Johns Hopkins University, Baltimore, USA) 
presented stability measurements on engineered proteins 
consisting of a variable number of consensus ankyrin 
repeats. Structurally, each ankyrin repeat is composed of 
two α-helices and each repeat packs against itself as well as 
neighboring repeats. By using consensus repeats of 
identical sequence, Barrick distinguished the energy of 
folding of each repeat from the energy of association with 
neighboring repeats. This analysis revealed that association 
of each subunit with its neighbors provides the energy to 
drive structure formation, and that the folding of individual 
subunits is on its own unfavorable.
Sarah Teichman (MRC Laboratory of Molecular Biology, 
Cambridge, UK) presented bioinformatic analyses indicat-
ing that protein structures have a preference for homo-
oligomerization. Of the structures deposited in the Protein 
Data Bank (PDB), 95% contain a single polypeptide 
sequence with one to eight subunits in the unit cell. 
Treichman described how counting the number of copies in 
the unit cell provides an estimation of the prevalence of 
different oligomeric forms. Utilizing this approach it was 
revealed that a distinct preference exists for homo-oligomers 
in general and for homo-oligomers with an even number of 
subunits in particular. These findings suggest that homo-
oligomers have an evolutionary advantage. The advantage 
was hypothesized to derive from the stability benefit of 
homo-oligomerization, enabling the sampling of increased 
mutational diversity without compromising folding.
Tight-binding inhibitors are highly sought after as 
potential drugs and Michael Kay (University of Utah, Salt 
Lake City, USA) gave an impressive presentation on the 
design of a class of multivalent tight-binding HIV fusion 
inhibitors. These inhibitors bind to a groove present in 
triplicate on the homotrimeric gp41 surface protein of HIV 
and hinder fusion of the virus with host cells. Kay described 
how, by utilizing flexible polyethylene glycol linkers to 
connect three binding motifs in one inhibitor molecule, the 
apparent binding affinity was lowered from a micromolar 
level to sub-nanomolar. As with most multivalent inter-
actions, the off-rates of the trivalent inhibitors were slowed 
because dissociation requires all three binding sites to 
dissociate at the same time. For the tightest-binding 
inhibitors, the off-rate was so slow that, once bound, the 
inhibitor-gp41 complex did not dissociate on biologically 
relevant timescales. With binding of this strength, infectivity 
was observed to be controlled by the on-rate kinetics and 
not by thermodynamic binding affinity. Because resistance 
mutations usually affect off-rates and not on-rates, these 
inhibitors were refractory to the development of drug 
resistance in multi-pass infectivity experiments.
Proteins that control membrane dynamics
Although many of the eukaryotic proteins involved in the 
dynamic behavior of membranes - in cell movement, 
endocytosis, exocytosis, and cell division - have been 
identified, many of the mechanisms by which they curve 
and pinch membranes into different configurations have 
yet to be elucidated. Pietro De Camilli (Yale University, 
New Haven, USA) showed, using fluorescence and electron 
microscopy combined with high-resolution structures, how 
the dimeric, banana-shaped BAR and F-BAR families of 
proteins interact with membranes to create and sense 
membrane curvature, which is necessary to form transport 
vesicles. Using synthetic giant unilamellar vesicles and 
fluorescence microscopy, Randy Schekman (University of 
California, Berkeley, USA), similarly demonstrated that the 
Sar1 GTPase, required for COP II vesicle trafficking of 
cargo between the endoplasmic reticulum and the Golgi 
complex, plays a direct role in creating membrane 
curvature for vesicle formation and scission. This reaction 
was highly dependent upon GTP and the amino-terminal 
helix of Sar1. Jenny Hinshaw (National Institute of 
Diabetes and Digestive and Kidney Diseases, NIH, 
Bethesda, USA) studies the large GTPase dynamin, and a 
related protein Dnm1, using cryo-electron microscopy. She 
presented remarkable images showing how the proteins 
self-associate on lipid tubules in a helical fashion. Upon 
GTP hydrolysis, they wrap tightly around each other to 
squeeze the membranes together, resulting in membrane 
constriction and scission.
In contrast to proteins that cause vesicle curvature and 
scission from the outside of the vesicle neck, the endosomal 
sorting complex required for transport III (ESCRT III) 
complex is used both for formation of internal endosome 
vesicles (the opposite orientation from budding of 
transport vesicles) and for the budding of HIV particles 
from the outside of the cell. Chris Hill (University of Utah, 
Salt Lake City, USA) described how the ESCRT III subunits 
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assemble into spirals that pinch off newly forming vesicles 
from the inside. Currently, the field awaits even higher-
resolution information, especially that of specific protein-
lipid and protein-protein interactions, in order to fully 
understand these mechanisms of vesicle scission.
The nuclear pore complex (NPC) was seemingly unrelated to 
vesicle budding, but turns out to have some striking 
similarities. Stephen Brohawn (Massachusetts Institute of 
Technology, Cambridge, USA) presented high-resolution 
structural data showing that several of the NPC subunits are 
homologous to the coat proteins (such as COP II) that shape 
newly forming vesicles, indicating a common ancestor for 
proteins that bend membranes. Andrej Sali (University of 
California, San Francisco, USA) presented a tour de force of 
computational, electron microscopic, biochemical and mass 
spectrometric approaches that has succeeded in modeling 
the entire NPC, which contains multiple copies of up to 30 
different proteins. Several of these proteins line the pore and 
are responsible for bending the membranes to form the 
pore, while others on the inside of the complex regulate 
traffic in and out of the pore.
Future challenges
Drug resistance is an unmistakable current and future 
challenge for the treatment of all human illnesses that 
involve rapidly multiplying genomes, which includes most 
viral and bacterial infections and cancer. Despite the 
diversity of illnesses affected by drug resistance, the field 
has just begun to appreciate that common molecular and 
physical principles form the foundation of resistance in 
seemingly unrelated illnesses. Simply stated, rapidly 
dividing organisms have the opportunity to sample many 
different mutations in the search for protein sequences 
that retain biological function while weakening binding to 
drug. These concepts were aptly presented by many 
speakers. Michael Eck (Harvard Medical School, Boston, 
USA) presented data showing that a drug-resistance 
mutation in the epidermal growth factor receptor caused 
increased affinity for its endogenous substrate ATP, which 
enabled ATP to out-compete the binding of the inhibitory 
drug. Madhavi Kolli (University of Massachusetts Medical 
School, Worcester, USA) provided evidence that in patients 
treated with HIV protease inhibitors, mutations in the 
protease and its substrates coevolve. For example, the 
multi-drug-resistant protease mutation I84V correlates 
with compensatory changes at the P1 cleavage site in the 
nucleocapsid substrate. In this case, the compensatory 
change in the nucleocapsid substrate site causes increased 
drug resistance. The field is beginning to appreciate the 
commonalities in drug-resistance mechanisms and the 
future hope is that this understanding will lead to the 
development of improved therapies.
One of the most pressing challenges in protein design is 
the ability to accurately predict charge-charge interactions. 
Electrostatic charge-charge interactions contribute greatly 
to the stable formation of protein structure and association 
of protein complexes, as well as to the binding of substrates 
and small-molecule effectors. Predicting the magnitude of 
charge-charge interactions is challenging because the 
dielectric constant and polarizability inside proteins is 
difficult to predict accurately. Bertrand Garcia-Moreno 
(Johns Hopkins University, Baltimore, USA) presented an 
impressive experimental characterization of the polariza-
bility at multiple positions within staphylococcal nuclease. 
Polarizability was determined by introducing ionizable 
amino acids and measuring their pKa shift. The data 
obtained from testing a family of 100 variants revealed that 
contrary to most computational models, the interior of this 
model protein was highly variable in its polarizability. This 
experimental analysis should enable improved future 
computational predictions of charge-charge interactions.
Overall, the meeting highlighted a number of exciting 
protein structures, functions and dynamics, and the wide 
variety of techniques and strategies used to understand 
them. We look forward to seeing many more at the next 
meeting, to be held in San Diego on 1-5 August 2010.
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